Peptide Drugs advanced
Semaglutide Insulin Coformulation
Experimental co-formulation of semaglutide with ultra-long-acting insulin for single-injection therapy.
By Encyclopeptide Editorial | 1 min read
insulin glp1-combination novel
Semaglutide Insulin Coformulation
Overview
Experimental co-formulation of semaglutide with ultra-long-acting insulin for single-injection therapy.
Structure
| Property | Value |
|---|---|
| Name | Semaglutide Insulin Coformulation |
Mechanism of Action
Combines GLP-1 agonist and basal insulin in single co-formulation for simplified treatment.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | Semaglutide Insulin Coformulation |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about Semaglutide Insulin Coformulation with interactive quizzes on Wikipept.
Take a Quiz on Wikipept